Literature DB >> 9135400

Presumed ocular histoplasmosis in The Netherlands--an area without histoplasmosis.

M S Suttorp-Schulten1, J G Bollemeijer, P J Bos, A Rothova.   

Abstract

AIMS/
BACKGROUND: The syndrome of ocular histoplasmosis is usually prefaced by "presumed' as the aetiology is not yet clear. The aim of this study was to evaluate the clinical features of a similar ocular syndrome in the Netherlands where the fungus Histoplasma capsulatum is not endemic.
METHODS: A retrospective multicentre study in which all patients were included who were diagnosed with a syndrome similar to presumed ocular histoplasmosis and in whom both fluorescein angiogram and all complete patient data were available. Fluorescein angiograms were examined by three authors in a masked fashion. Eighty one patients were selected who fulfilled the ophthalmic criteria for presumed ocular histoplasmosis. Fifty one patients showed the classic clinical picture, while 30 patients had an incomplete form as they did not show numerous histospots.
RESULTS: No major difference in clinical characteristics could be identified when comparing the group of patients with the classic syndrome with the one with the incomplete syndrome. Final visual outcome of patients with macular subretinal neovascularisation after laser treatment was better when compared with untreated patients (p < 0.01).
CONCLUSIONS: Since the fungus Histoplasma capsulatum is absent in the Netherlands, other aetiological agents must have led to this clinical entity similar to the presumed ocular histoplasmosis syndrome seen in the USA.

Entities:  

Mesh:

Year:  1997        PMID: 9135400      PMCID: PMC1722002          DOI: 10.1136/bjo.81.1.7

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  37 in total

1.  PRESUMED HISTOPLASMIC CHOROIDITIS. A CLINICAL ANALYSIS OF 43 CASES.

Authors:  D WALMA; T F SCHLAEGEL
Journal:  Am J Ophthalmol       Date:  1964-01       Impact factor: 5.258

2.  SPECIFIC OCULAR UVEAL LESIONS IN PATIENTS WITH EVIDENCE OF HISTOPLASMOSIS.

Authors:  T E VAN METRE; A E MAUMENEE
Journal:  Arch Ophthalmol       Date:  1964-03

3.  The probable role of benign histoplasmosis in the etiology of granulomatous uveitis.

Authors:  A C WOODS; H E WAHLEN
Journal:  Am J Ophthalmol       Date:  1960-02       Impact factor: 5.258

4.  Intraocular tumor from disseminated histoplasmosis.

Authors:  S S Feman; P Pritchett; K Johns; D J Westrich; W D Salmon
Journal:  South Med J       Date:  1991-06       Impact factor: 0.954

5.  Experimental ocular histoplasmosis.

Authors:  R DAY
Journal:  Am J Ophthalmol       Date:  1949-10       Impact factor: 5.258

6.  Immunopathology of chronic experimental histoplasmic choroiditis in the primate.

Authors:  A Anderson; W Clifford; I Palvolgyi; L Rife; C Taylor; R E Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

7.  Lack of the HLA-DR2 specificity in multifocal choroiditis and panuveitis.

Authors:  R F Spaide; J E Skerry; L A Yannuzzi; J T DeRosa
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

8.  Immunopathology of reactivation of experimental ocular histoplasmosis.

Authors:  I Palvolgyi; A Anderson; L Rife; C Taylor; R E Smith
Journal:  Exp Eye Res       Date:  1993-08       Impact factor: 3.467

9.  Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome.

Authors:  C S Specht; K T Mitchell; A E Bauman; M Gupta
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

10.  Long-term results of laser treatment in the ocular histoplasmosis syndrome.

Authors:  H L Cummings; A J Rehmar; W J Wood; R D Isernhagen
Journal:  Arch Ophthalmol       Date:  1995-04
View more
  3 in total

1.  Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands.

Authors:  J V Ongkosuwito; L M Kortbeek; A Van der Lelij; E Molicka; A Kijlstra; M D de Smet; M S Suttorp-Schulten
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.

Authors:  Joachim Wachtlin; Heinrich Heimann; Tim Behme; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

3.  Presumed ocular histoplasmosis syndrome in a commercially insured population, United States.

Authors:  Kaitlin Benedict; Jessica G Shantha; Steven Yeh; Karlyn D Beer; Brendan R Jackson
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.